Frequency of Bioprosthetic Valve Fracturing Utilization in an All-Comers Valve-in-Valve TAVR Cohort
Introduction: Valve-in-valve TAVR (ViV-TAVR) is an established treatment for failing surgical aortic valves in patient at high surgical risk. Elevated transprosthetic gradients are common after ViV-TAVR. Previously, bench tests showed feasibility of bioprosthetic valve fracturing (VF) using high-pre...
Main Authors: | Hendrik Ruge, Magdalena Erlebach, Ruediger Lange |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.653871/full |
Similar Items
-
Bioprosthetic Valve Fracturing: In vitro Testing of Edwards PERIMOUNT Model P 2900
by: Hendrik Ruge, et al.
Published: (2022-06-01) -
Results of new-generation balloon vs. self-expandable transcatheter heart valves for bicuspid aortic valve stenosis
by: Oliver Deutsch, et al.
Published: (2023-09-01) -
First-in-Man Simultaneous Aortic and Mitral Valve Transcatheter Implantation Using Patient-Customized Prostheses
by: Hendrik Ruge, MD, et al.
Published: (2021-04-01) -
Incidence and Outcomes of Valve-in-Valve Transcatheter Aortic Valve Implantation in Failed Bioprosthetic Valves
by: Thorald Stolte, et al.
Published: (2023-09-01) -
Differences in Inpatient Outcomes After Surgical Aortic Valve Replacement at Transcatheter Aortic Valve Replacement (TAVR) and Non‐TAVR Centers
by: Godly Jack, et al.
Published: (2019-11-01)